Influenza Vaccine

Influenza Vaccine

The influenza vaccination, also known as a flu shot, is an annual vaccination using a vaccine specific for a given year to protect against the highly variable influenza virus. Each seasonal influenza vaccine contains three influenza viruses: one influenza type A subtype H3N2 virus strain, one influenza type A subtype H1N1 (seasonal) virus strain, and one influenza type B virus strain. A quadrivalent flu vaccine administered by nasal mist was approved by the U.S. Food and Drug Administration (FDA) in March 2012.

Read more about Influenza VaccinePurpose and Benefits of Annual Flu Vaccination, History of The Flu Vaccine, High-dose Vaccine, Vaccination Recommendations, Cost-effectiveness, Side Effects, Flu Vaccine Manufacturing, H5N1, Annual Reformulation of Flu Vaccine, Flu Vaccine For Nonhumans, Computer-assisted Vaccine Design

Other articles related to "influenza vaccine, influenza, vaccine, influenza vaccines":

Influenza Vaccine - Computer-assisted Vaccine Design
... defined to quantify the antigenic distance between two H3N2 influenza strains ... distance between circulating H3N2 strains and the closest vaccine component of the influenza vaccine ... with efficacy in humans of the H3N2 influenza A annual vaccine than did current measures of antigenic distance such as phylogenetic sequence analysis or ferret antisera inhibition assays ...
ACAM-FLU-A - Annual Reformulation of Flu Vaccine
... Further information Historical annual reformulations of the influenza vaccine See also 2009 flu pandemic vaccine Each year, three strains are chosen ... Hemisphere influnza season (coincident with the approval of quadrivalent influenza vaccines) the WHO has also recommended a 2nd B-strain for use in ... The World Health Organization coordinates the contents of the vaccine each year to contain the most likely strains of the virus to attack the next year ...
Influenza Research - Vaccines - Pandemic Flu Vaccine Planning
... United States Department of Health and Human Services (HHS) Pandemic Influenza Plan Appendix F Current HHS Activities last revised on November 8, 2005 Currently, influenza vaccine for the annual ... only a single manufacturer produces the annual vaccine entirely within the U.S ... Thus, if a pandemic occurred and existing U.S.-based influenza vaccine manufacturing capacity was completely diverted to producing a pandemic vaccine, supply would be severely limited ...
Fluenz - Groups For Whom FluMist Is Recommended
... Influenza vaccine is a cost-effective counter-measure to the threat of seasonal or pandemic outbreaks of influenza ... Canada, currently recommends that everyone aged 2 to 64 years be encouraged to receive annual influenza vaccination, and that children between the age of 6 and 24 months, and their ... FluMist is a vaccine of demonstrated effectiveness against seasonal influenza ...